FDA approves first medical treatment for Alzheimer’s in 18 years
Catch up with NBC News Clone on today's hot topic: Fda Approves First Medical Treatment For Alzheimer S In 18 Years 114445381880 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.
01:30
Copied
The drug aducanumab, developed by the company Biogen, attacks the amyloid protein that builds up in the brain of Alzheimer’s patients. The drug is going on the market even though the FDA says there are “uncertainties regarding clinical benefits” and is requiring Biogen to do another clinical trial.June 7, 2021